30 November 2009
Uncommon cutaneous lesions under immunosuppressive therapy
Keiji Sugiura, Mariko Sugiura, Tsuneo Ueki, Norihiko Goto, Akio Katayama, Akira ItoAm J Case Rep 2009; 10:218-220 :: ID: 878285
Abstract
Background: Sarcoidosis may be induced by CD4 T helper cell type-1 T-lymphocytes. Because the action process of cyclosporine inhibits IL-2 mediated T cells, cyclosporine is not sufficient to inhibit sarcoidosis.
Case Report: A 45-year-old man receiving immunosuppressive therapy developed erythema and scales on his face in 2007. Our diagnosis was sarcoidal granulomas based on immunohistopathological findings and no results of polymerase chain reaction for TB or mycobacterium analysis. We treated the patient
using steroid tablets and ointment, which, combined with a pulsed light system for telangiectasia, improved his condition.
Conclusions: This is a common cutaneous disease that occurs after renal transplantation, as has been seen in clinical findings. Although the patient’s conditions developed under immunosuppressive therapy, the treatment had to involve adequate steroids for the treatment of sarcoidosis after renal transplantation. Because cyclosporine was used, the occurrence of sarcoidal granulomas is an uncommon findings result.
Keywords: renal transplantation, Granuloma, sarcoidosis, immunosuppressive therapy, steroid
589 4
In Press
25 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939239
24 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939520
24 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939697
23 May 2023 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.939642
Most Viewed Current Articles
06 Dec 2021 : Case report
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
13 Jul 2022 : Case report
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
07 Dec 2021 : Case report
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347